Reuters logo
3 months ago
BRIEF-Astellas Pharma says transfer of 16 Long-Listed Products in Japan to LTL Pharma
April 28, 2017 / 6:55 AM / 3 months ago

BRIEF-Astellas Pharma says transfer of 16 Long-Listed Products in Japan to LTL Pharma

1 Min Read

April 28 (Reuters) - Astellas Pharma Inc

* Says Astellas and LTL Pharma Co., Ltd.confirmed the relevant closing conditions are met on April 28 to allow the transfer of the assets related to Astellas’ 16 long-listed products in Japan to LTL Pharma

* Astellas and LTL Pharma have now satisfied the pre-agreed conditions to close the transaction, with Astellas having received 20.1 billion yen as a result

Source text in Japanese:goo.gl/mw3vLH

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below